Multifocal electroretinography N1-P1 response density

There is 1 paper on multifocal electroretinography N1-P1 response density in aging research: 1 trial in people.

Biomarker

1 paper studies it1 finding

See all 1 papers on multifocal electroretinography N1-P1 response density

  • Human trial1

Interventions

1

UBX1325

upin humans1

1 study
  1. UBX1325 increases multifocal electroretinography N1-P1 response density in neovascular AMD subjects with prior anti-VEGF injections (≥20% gain in three of five subjects at Week 8).

    “After foselutoclax treatment, the largest improvement in the mfERG N1-P1 response density occurred at Week 8 as three of five subjects achieved a ≥20% gain.”

    Human trialin neovascular AMD subjects with prior anti-VEGF injectionsretina50 μL intravitreal injectionn = 5

    Multifocal Electroretinography Changes after UBX1325 (Foselutoclax) Treatment in Neovascular Age-Related Macular Degeneration

    Journal of clinical medicine

More on UBX1325

Latest